Answers are grounded in this paper and cite their sources.
= 40), most of whom identified as a sexual minority (97.3%). Participants showed reductions in appearance concerns, eating disorder symptoms, social anxiety, and overvaluation of appearance that were maintained one-month after treatment. Taken together, the present investigation suggests that ARSBs are also clinically relevant in men, and ARSB fading shows similar efficacy in men as it does in women.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: